focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,774.50
Ask: 1,775.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.056%)
Open: 1,775.50
High: 1,778.50
Low: 1,769.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Dividends Calendar - Week Ahead

Fri, 01st Aug 2014 05:21

UK Dividends Calendar 
Friday, August 1 
Tate & LylePayment date 2013 dividend
United UtilitiesPayment date 2013 dividend
Carphone Warehouse GroupPayment date 2014 dividend
NextPayment date 2013 dividend
Electronic Data ProcessingPayment date 2014 dividend
N BrownPayment date 2014 dividend
De La RuePayment date 2014 dividend
Dee Valley GroupPayment date 2014 dividend
HomeservePayment date 2014 dividend
Mercantile Investment TrustPayment date 2014 dividend
CML MicrosystemsPayment date 2014 dividend
Halfords GroupPayment date 2014 dividend
KCOM GroupPayment date 2014 dividend
North American Income TrustPayment date 2014 dividend
Shanks GroupPayment date 2014 dividend
TalkTalk Telecom GroupPayment date 2014 dividend
Telecom PlusPayment date 2014 dividend
Foreign & Colonial Investment TrustPayment date 2014 dividend
Workspace GroupPayment date 2014 dividend
NextSpecial Dividend Payment Date
Monday, August 4 
Establishment Investment TrustPayment date 2013 dividend
JD Sports FashionPayment date 2013 dividend
Tuesday, August 5 
e2v technologiesPayment date 2014 dividend
Johnson MattheyPayment date 2014 dividend
TR Property Investment TrustPayment date 2014 dividend
Wednesday, August 6 
Pennon GroupEx-dividend date 2014
Aberdeen New Dawn ITEx-dividend date 2014
Aberforth Smaller Companies TrustEx-dividend date 2014
CrestonEx-dividend date 2014
Impellam GroupEx-dividend date 2014
BarclaysEx-dividend date 2014
BPEx-dividend date 2014
Domino's Pizza GroupEx-dividend date 2014
Dunedin Income Growth Investment TrustEx-dividend date 2014
Aberdeen UK Tracker TrustEx-dividend date 2014
GlaxoSmithKlineEx-dividend date 2014
Henderson Far East IncomeEx-dividend date 2014
HiscoxEx-dividend date 2014
Independent Investment TrustEx-dividend date 2014
Henderson Far East IncomeEx-dividend date 2014
MITIE GroupPayment date 2014 dividend
QinetiQ GroupEx-dividend date 2014
Reckitt BenckiserEx-dividend date 2014
Reed ElsevierEx-dividend date 2014
RPC GroupEx-dividend date 2014
St. Modwen PropertyEx-dividend date 2014
Synergy HealthEx-dividend date 2014
Target Healthcare REITEx-dividend date 2014
UK Commercial Property TrustEx-dividend date 2014
UnileverEx-dividend date 2014
Vodafone GroupEx-dividend date 2014
Anglo AmericanEx-dividend date 2014
SABMillerEx-dividend date 2014
Advanced Computer Software GroupEx-dividend date 2014
Eco Animal HealthEx-dividend date 2014
TymanEx-dividend date 2014
Aberforth Geared Income TrustEx-dividend date 2014
Custodian REITEx-dividend date 2014
Aberforth Geared Income TrustSpecial Dividend Payment Date
Thursday, August 7 
ITE GroupPayment date 2014 dividend
Dairy Crest GroupPayment date 2014 dividend
Anglo Pacific GroupPayment date 2014 dividend
Caledonia InvestmentsPayment date 2014 dividend
WH SmithPayment date 2014 dividend
  
Copyright 2014 Alliance News Limited. All Rights Reserved.
  

More News
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.